Aggressive Lymphomas / Hematologic Malignancies (PDF)

Name: Aggressive Lymphomas / Hematologic Malignancies
Brand: Springer-Verlag GmbH
SKU: 110002722
Price: 128.39 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Aggressive Lymphomas / Hematologic Malignancies".

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 128.39 €

Buch (Gebunden) 139.09 €

sofort als Download lieferbar

Bestellnummer: 110002722

Printausgabe 139.09 €

eBook (pdf) -8% 128.39 €

Download bestellen

Verschenken

64 DeutschlandCard Punkte sammeln

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Aggressive Lymphomas / Hematologic Malignancies (PDF)“

This book summarizes current knowledge of the biology and molecular pathogenesis of aggressive lymphomas and reviews the state of the art in diagnostic and therapeutic strategies. The aim is both to provide the reader with a sound understanding of the very significant progress that has been achieved in the understanding and management of these malignancies over recent years and to facilitate appropriate choice of the therapeutic strategy in individual cases. The assessment of different prognostic parameters are clearly presented in order to permits effective risk stratification that impacts on treatment choice. Recent insights into lymphomagenesis are exemplified and may assist in identifying emerging therapeutic targets. The comprehensive and up-to-date nature of the book will make it an ideal reference for all physicians and researchers interested in lymphoma, including clinicians from various medical specialties, biologists, pathologists, radiologists and nuclear medicinespecialist, as well as students.

Autoren-Porträt

Professor Georg Lenz is Director of the Department of Medicine A, Hematology, Oncology and Pneumology at the University Hospital in Münster, Germany. Before his move to Münster he previously worked at the Ludwig-Maximilians University Munich, the National Cancer Institute in Bethesda (USA), and the Charité - Universitätsmedizin Berlin. His basic and clinical research focuses on the molecular characterization of malignant lymphomas and the performance of clinical trials using specific therapeutics.

Professor Gilles Salles is Head of the Hematology Department in Lyon University Hospitals (Hospices Civils de Lyon & Université Claude Bernard Lyon-1) and co-director of the research team "Clinical and Experimental Models of Lymphoma" at the Cancer Research Center of Lyon (Institut National de la Santé et de la Recherche Médicale). He trained in Hematology and Immunology at the Université Claude Bernard in Lyon and at the Dana Farber Cancer Institue (Havard Medical Scholl, Boston, USA). He conducted several leading international clinical trials as well as translational studies in the field of lymphoma.